Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

Abstract Background In B cell non-Hodgkin lymphoma (B-NHL), rituximab-containing reduced-intensity conditioning regimens (R-RIC) have been shown to provide favorable outcomes in single-arm studies; however, large multicenter studies comparing R-RIC and non-rituximab-containing reduced-intensity cond...

Full description

Bibliographic Details

Published in:	Journal of Hematology & Oncology
Main Authors:	Narendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, Madan Jagasia, Alyssa DiGilio, Steven M. Devine, Samantha Jaglowski, Vanessa Kennedy, Andrew R. Rezvani, Sonali M. Smith, Anna Sureda, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Phillipe Armand, Mehdi Hamadani
Format:	Article
Language:	English
Published:	BMC 2017-06-01
Subjects:	Rituximab Reduced-intensity conditioning Allogeneic hematopoietic cell transplant Lymphoma
Online Access:	http://link.springer.com/article/10.1186/s13045-017-0487-y